Andrew A. Hindman

Insider Reports History

Entity
Individual
Location
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew A. Hindman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP, CHIEF FINANCIAL OFFICER Ordinary Shares 385K $3.96M $10.29 Nov 20, 2022 Direct

Insider Reports Filed by Andrew A. Hindman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TBPH Theravance Biopharma, Inc. Nov 18, 2022 2 -$988K 4 Nov 22, 2022 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Aug 19, 2022 1 -$240K 4 Aug 23, 2022 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Jul 25, 2022 1 $0 4 Jul 27, 2022 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. May 20, 2022 1 -$29.4K 4 May 24, 2022 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Feb 18, 2022 1 -$250K 4 Feb 23, 2022 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Dec 2, 2021 1 $0 4 Dec 6, 2021 SVP, Chief Financial Officer
TBPH Theravance Biopharma, Inc. Nov 19, 2021 1 -$11.3K 4 Nov 23, 2021 SVP, CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Aug 20, 2021 1 -$245K 4 Aug 24, 2021 SVP, Chief Financial Officer
TBPH Theravance Biopharma, Inc. May 20, 2021 1 -$16.8K 4 May 24, 2021 SVP, Chief Financial Officer